...
首页> 外文期刊>Journal of cellular biochemistry. >Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.
【24h】

Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.

机译:通过抑制有丝分裂原激活的蛋白激酶和AKT途径,通过热激蛋白20抑制肝癌细胞的增殖。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Heat shock protein (HSP) 20, one of the low-molecular weight HSPs, is known to have versatile functions, such as vasorelaxation. However, its precise role in cancer proliferation remains to be elucidated. While HSP20 is constitutively expressed in various tissues including the liver, we have previously reported that HSP20 protein levels in human hepatocellular carcinoma (HCC) cells inversely correlate with the progression of HCC. In this study, we investigated the role of HSP20 in HCC proliferation. The activities of extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), and AKT were negatively correlated with the HSP20 protein levels in human HCC tissues. Since HSP20 proteins were hardly detected in HCC-derived cell lines, the effects of HSP20 expression were evaluated using human HCC-derived HuH7 cells that were stably transfected with wild-type human HSP20 (HSP20 overexpressing cells). In HSP20 overexpressing cells, cell proliferation was retarded, and the activation of the mitogen-activated protein kinases (MAPKs) signaling pathways, including the ERK and JNK, and AKT pathways, as well as cyclin D1 accumulation induced by either transforming growth factor-alpha (TGFalpha) or hepatocyte growth factor, were significantly suppressed compared with the empty vector-transfected cells (control cells). Taken together, our findings strongly suggest that HSP20 suppresses the growth of HCC cells via the MAPKs and AKT signaling pathways, thus suggesting that the HSP20 could be a new therapeutic target for HCC.
机译:低分子量HSP之一的热激蛋白(HSP)20具有多种功能,例如血管舒张。然而,其在癌症扩散中的确切作用仍有待阐明。虽然HSP20在包括肝脏在内的各种组织中组成性表达,但我们先前已经报道过人类肝细胞癌(HCC)细胞中的HSP20蛋白水平与HCC的进展呈负相关。在这项研究中,我们调查了HSP20在HCC增殖中的作用。细胞外信号调节激酶(ERK),c-jun N末端激酶(JNK)和AKT的活性与人肝癌组织中HSP20蛋白水平呈负相关。由于在HCC衍生的细胞系中几乎未检测到HSP20蛋白,因此使用被野生型人HSP20(HSP20过表达的细胞)稳定转染的人HCC衍生的HuH7细胞评估了HSP20表达的效果。在HSP20过表达的细胞中,细胞增殖受到阻碍,丝裂原激活的蛋白激酶(MAPKs)信号传导途径(包括ERK和JNK和AKT途径)的活化以及通过转化生长因子-α诱导的细胞周期蛋白D1积累与空载体转染的细胞(对照细胞)相比,(TGFα)或肝细胞生长因子被显着抑制。综上所述,我们的发现强烈提示HSP20通过MAPK和AKT信号通路抑制HCC细胞的生长,因此表明HSP20可能是HCC的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号